1265.8000 -2.80 (-0.22%)
NSE Dec 30, 2025 15:31 PM
Volume: 1.1M
 

logo
Dr. Reddy's Laboratories Ltd.
29 Oct 2020, 12:00AM
1265.80
-0.22%
ICICI Securities Limited
Q2 revenues grew 2.0% YoY to | 4911 crore (I-direct estimate: | 4564 crore) mainly due to strong growth across segments partly offset by high base effect in Q2FY20 (divestiture of certain proprietary products). US revenues grew 28.5% YoY to | 1833 crore on the back of rupee depreciation and new product launches. Domestic revenues grew 21.5% YoY to | 912 crore due to Wockhardt integration and Covid products. Europe revenues grew 35.8% YoY to | 375 crore due to new launches and currency tailwinds. PSAI segment posted a robust 19.7% YoY growth to | 851 crore. EBITDA margins...
Dr. Reddy's Laborato.. has an average target of 1281.89 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended